<DOC>
	<DOCNO>NCT02714400</DOCNO>
	<brief_summary>The investigator hypothesis obstructive sleep apnea ( OSA ) patient low arousal threshold may wake early respiratory event , upper airway muscle activate achieve stable ventilation . Thus , strategy manipulate respiratory arousal threshold could potentially improve quality sleep sleep disorder breathing . Agents raise arousal threshold therefore likely benefit patient OSA . The overall goal project determine importance arousal threshold OSA , determine patient might benefit raise arousal threshold , test hypothesis use pharmacological manipulation arousal threshold achieve goal .</brief_summary>
	<brief_title>The Impact Venlafaxine Apnea Hypopnea Index Obstructive Sleep Apnea</brief_title>
	<detailed_description>This study randomize double-blinded crossover pilot study . The investigator test whether Venlafaxine important effect apnea hypopnea index . Venlafaxine serotonin-norepinephrine reuptake inhibitor ( SNRI ) treatment depression anxiety . Venlafaxine increase serum serotonin level , may affect arousal threshold . Furthermore , high serotonin level theoretically may improve muscle tone , include upper airway muscle . Therefore , investigator hypothesize venlafaxine may decrease arousal threshold improve muscle tone , lead improvement OSA . Eligible participant undergo overnight polysomonography describe receive either Venlafaxine ( 50 mg 2 hour prior sleep ) placebo ( random order ) follow roughly 7 day later placebo donepezil . This aim allow u test impact Venlafaxine apnea hypopnea index . The change apnea hypopnea index compare Venlafaxine group placebo group .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Ages 1870 year sleep study ( apnea hypopnea index &gt; 5 ) Diagnosis obstructive sleep apnea Any known cardiac ( apart treat hypertension ) , pulmonary ( include uncontrolled asthma ) , renal , neurologic ( include epilepsy ) , neuromuscular , hepatic disease . Susceptible stomach ulcer . coadministration MAO inhibitor intend treat psychiatric disorder ( concurrently within 14 day discontinue MAO inhibitor ) ; initiation MAO inhibitor intend treat psychiatric disorder within 7 day discontinue venlafaxine ; initiation patient receive linezolid intravenous methylene blue Pregnant woman . History hypersensitivity Afrin , Lidocaine ( Aims ) venlafaxine History bleed diathesis and/or gastrointestinal bleeding . Glaucoma Urinary Retention Use medication may affect sleep breathing . Use medication know interaction venlafaxine interaction may significantly increase risk subject decrease therapeutic effect medication . A psychiatric disorder , mild depression ; e.g . schizophrenia , bipolar disorder , major depression , panic anxiety disorder . Substantial cigarette ( &gt; 5/day ) , alcohol ( &gt; 3oz/day ) use illicit drug . More 10 cup beverage caffeine ( coffee , tea , soda/pop ) per day . Desaturations 70 % lasting great 10 second duration per event</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Arousal threshold</keyword>
	<keyword>Venlafaxine</keyword>
</DOC>